API
Risperidone
KDMF APIs
Risperidone
Korean name | 리스페리돈 |
|---|---|
Category | Central nervous system |
CAS No. | 106266-06-2 |
KDMF registration No. | 20151130-10-C-349-20 20070521-10-C-231-14(1) |
Manufacturer | Mylan Laboratories Limited Aurobindo Pharma ltd. |
Specification | EP |
Product information
IUPAC Name | RAPZEAPATHNIPO-UHFFFAOYSA-N |
|---|---|
Description | Risperidone is a second-generation antipsychotic (SGA) medication used in the treatment of a number of mood and mental health conditions including schizophrenia, bipolar mania, and as an adjunct in severe depression for example. It is one of the most widely used SGAs. Schizophrenia and various mood disorders are thought to be caused by an excess of dopaminergic D2 and serotonergic 5-HT2A activity, resulting in overactivity of central mesolimbic pathways and mesocortical pathways, respectively. Risperidone is thought to reduce this overactivity through inhibition of dopaminergic D2 receptors and serotonergic 5-HT2A receptors in the brain. Risperidone binds with a very high affinity to 5-HT2A receptors, approximately 10-20 fold greater than the drug's binding affinity to D2 receptors |
Certificate of Analysis | If you need more information, please contact us. |
If you need additional documents such as specifications or certificates of analysis, please request them together with your inquiry. Our team will review and reply. (02-579-1056 · ace@acebiopharm.com)